Pharma-Bio Serv, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $21.8M | $13.8M |
| FY2017 | — | $20.7M | $11.6M |
| FY2018 | — | $20.3M | $16.0M |
| FY2019 | — | $20.6M | $15.5M |
| FY2020 | — | $22.7M | $17.1M |
| FY2021 | — | $18.9M | $17.5M |
| FY2022 | — | $16.6M | $14.5M |
| FY2023 | — | $16.1M | $10.4M |
| FY2024 | — | $13.7M | $6.8M |
| FY2025 | — | $11.9M | $3.4M |